Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Total Liabilities : ¥2,732 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Anhui Fengyuan Pharmaceutical Co Total Liabilities?

Anhui Fengyuan Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥2,732 Mil.

Anhui Fengyuan Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (¥2,264.66 Mil) to Dec. 2023 (¥2,472.49 Mil) and increased from Dec. 2023 (¥2,472.49 Mil) to Mar. 2024 (¥2,732.35 Mil).

Anhui Fengyuan Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥2,287.73 Mil) to Dec. 2022 (¥2,714.48 Mil) but then declined from Dec. 2022 (¥2,714.48 Mil) to Dec. 2023 (¥2,472.49 Mil).

Anhui Fengyuan Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Anhui Fengyuan Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Fengyuan Pharmaceutical Co Total Liabilities Chart

Anhui Fengyuan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2,232.50

2,251.00

2,287.73

2,714.48

2,472.49

Anhui Fengyuan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,599.09	2,587.46	2,264.66	2,472.49	2,732.35

Anhui Fengyuan Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Anhui Fengyuan Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2013.636	+	(194.964	+	263.894
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,472

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	4391.32	-	1918.826
	=	2,472

Anhui Fengyuan Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2252.977	+	(219.254	+	260.117
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,732

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	4703.099	-	1970.751
	=	2,732

Anhui Fengyuan Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Anhui Fengyuan Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 108, Beimenwai Street, Wuwei County, Anhui Province, Hefei, CHN, 230051

Website

http://www.bbcayy.com

Anhui Fengyuan Pharmaceutical Co Ltd operates in pharmaceutical research and development, production, and sales. The business of the company includes preparations, API, health care, and commercial logistics. The company is engaged in development of bio innovative drugs and in set up of drug distribution branches.

Executives

Li Guo Kun

Executives

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Headlines

No Headlines